Alpine Investors Acquires AirDNA

AirDNA Acquires Arrivalist

July 17, 2023

Data & Analytics

AirDNA, a Denver-based short-term rental data provider, has acquired Arrivalist, a location intelligence platform serving the travel and hospitality industry. The deal brings Arrivalist into predictis (a portfolio of Alpine Investors) as an add-on to expand AirDNA’s location and travel-data capabilities and product offerings for DMOs, hotels, and travel marketers.

AirDNA Acquires Uplisting to Expand into Property-Management Tech

January 9, 2024

Cloud & SaaS

AirDNA, a predictis portfolio company backed by Alpine Investors, has acquired Uplisting, a vacation rental property management and channel management software provider. The deal brings Uplisting’s booking, operations and channel-sync capabilities into AirDNA’s data and pricing platform, enabling integrated dynamic pricing and end-to-end tools for short-term rental hosts and managers.

Horizon Capital-backed STRAT7 Acquires Crowd DNA

November 25, 2020

Marketing & Advertising

STRAT7, a Horizon Capital‑backed customer analytics and insights group, has acquired cultural insights and strategy consultancy Crowd DNA. The deal brings Crowd DNA’s global cultural insight capability and offices (London, Amsterdam, New York, Singapore, Sydney) into STRAT7’s analytics and customer‑centric transformation proposition to better serve global brands.

Alpine 4 Holdings Acquires Identified Technologies

October 20, 2021

Software

Alpine 4 Holdings (A4) has acquired Identified Technologies, a Pittsburgh-based drone mapping software and managed services provider. The business will be integrated into Alpine 4's A4 Aerospace portfolio to add drone mapping and analytics capabilities to the company's aerospace offerings.

Vertex Pharmaceuticals Acquires Alpine Immune Sciences

April 10, 2024

Biotechnology

Vertex Pharmaceuticals will acquire Alpine Immune Sciences for $65 per share (approximately $4.9 billion) in cash. The acquisition adds Alpine’s lead candidate povetacicept (ALPN‑303) and protein-engineering/immunotherapy capabilities to Vertex’s pipeline and is expected to close in Q2 2024, subject to customary conditions.

Integrated Partners Adds San Diego-based RetirementDNA

January 25, 2025

Wealth Management

Integrated Partners, a national RIA serving over $20 billion in assets under advisement, announced that San Diego-based RetirementDNA has joined its network. The deal expands Integrated Partners' West Coast presence and strengthens its retirement plan and private wealth management capabilities by providing RetirementDNA access to Integrated's institutional resources and CPA alliance program.